Real-time enrollment status for this tardive dyskinesia clinical trial
Current Status
Recruiting
Checked: March 2, 2026 at 11:51 AM UTC
| NCT Number | NCT07105111 |
| Recruiting Status | Recruiting |
| Condition | Tardive Dyskinesia |
| Phase | Clinical Trial |
| Target Enrollment | 50 participants |
| Active Locations | 5 sites in the US |
| Sponsor | Neurocrine Biosciences |
| Last Updated on CT.gov | October 22, 2025 (Oct 22, 2025) |
As of March 2, 2026: Clinical trial NCT07105111 is currently recruiting participants. This clinical trial study for tardive dyskinesia is actively seeking new participants at 5 locations across the United States. The study is sponsored by Neurocrine Biosciences. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07105111 is actively recruiting participants as of March 2, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 5 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07105111 was last updated Oct 22, 2025 (October 22, 2025). HelloStudys verifies this status automatically.